Global coagulation assays detect an early prothrombotic state in children with acute lymphoblastic leukemia

Betticher, Coralie; Bertaggia Calderara, Debora; Matthey-Guirao, Elena; Gomez, Francisco J.; Aliotta, Alessandro; Lemmel, Elena; Ceppi, Francesco; Alberio, Lorenzo; Rizzi, Mattia

doi:10.1016/j.jtha.2024.05.032

Journal of Thrombosis and Haemostasis

2024

DOI: 10.1016/j.jtha.2024.05.032

|View full text |Cite

Global coagulation assays detect an early prothrombotic state in children with acute lymphoblastic leukemia

Coralie Betticher,

Debora Bertaggia Calderara,

Elena Matthey-Guirao

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 55 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Update on Cancer-Associated Venous Thromboembolism in Children

Kasteler,

Albisetti,

Bosch

2024

Hamostaseologie

View full text Add to dashboard Cite

Children with cancer have an increased risk for venous thromboembolic events (VTEs) compared to the healthy pediatric population. VTE rates in children with cancer vary among cancer types. Other VTE risk factors include central venous catheters and cancer therapies. VTE diagnosis relies on objective radiological imaging, and management to this date typically involves anticoagulant therapy. Low-molecular-weight heparins (LMWHs) are the most common choice. Evidence for primary VTE prevention is conflicting, and antithrombin replacement, LMWH, or apixaban have been studied. Recently, direct oral anticoagulants such as rivaroxaban or dabigatran were investigated for VTE treatment, showing promise in efficacy and safety. However, bleeding risks in this population need careful consideration, especially periprocedurally or with treatment-related thrombocytopenia. Prediction tools for VTE require adaptation for pediatric cancer patients. Progress in understanding and managing VTE in children with cancer is significant, with ongoing trials and real-world data contributing to improved strategies.

show abstract

Update on Cancer-Associated Venous Thromboembolism in Children

Kasteler,

Albisetti,

Bosch

2024

Hamostaseologie

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Global coagulation assays detect an early prothrombotic state in children with acute lymphoblastic leukemia

Cited by 1 publication

References 55 publications

Update on Cancer-Associated Venous Thromboembolism in Children

Update on Cancer-Associated Venous Thromboembolism in Children

Contact Info

Product

Resources

About